References
- Aldars-García L, Chaparro M, Gisbert JP. Systematic review: the gut microbiome and its potential clinical application in inflammatory bowel disease. Microorganisms. 2021 Apr;9(5):977. https://doi.org/10.3390/microorganisms9050977
- Arrieta MC, Stiemsma LT, Dimitriu PA, Thorson L, Russell S, Yurist-Doutsch S, Kuzeljevic B, Gold MJ, Britton HM, Lefebvre DL, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med. 2015 Sep;7(307):307ra152. https://doi.org/10.1126/scitranslmed.aab2271
- Assimakopoulos SF, Triantos C, Maroulis I, Gogos C. the role of the gut barrier function in health and disease. Gastroenterology Res. 2018 Aug;11(4):261–263. https://doi.org/10.14740/gr1053w
- Bunyavanich S, Shen N, Grishin A, Wood R, Burs W, Dawson P, Jones SM, Leung DYM, Sampson H, Sicherer S, et al. Early-life gut microbiome composition and milk allergy resolution. J Allergy Clin Immunol. 2016 Oct;138(4):1122–1130. https://doi.org/10.1016/j.jaci.2016.03.041
- Davies TF, Andersen S, Latif R, Nagayama Y, Barbesino G, Brito M, Eckstein AK, Stagnaro-Green A, Kahaly GJ. Graves’ disease. Nat Rev Dis Primers. 2020 Jul;6(1):52. https://doi.org/10.1038/s41572-020-0184-y
- Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013 Oct;10(10):996–998. https://doi.org/10.1038/nmeth.2604
- Ehlers M, Schott M, Allelein S. Graves’ disease in clinical perspective. Front Biosci (Landmark Ed). 2019 Jan;24(1):35–47. https://doi.org/10.2741/4708
- Friedman JE, Dobrinskikh E, Alfonso-Garcia A, Fast A, Janssen RC, Soderborg TK, Anderson AL, Reisz JA, D’Alessandro A, Frank DN, et al. Pyrroloquinoline quinone prevents developmental programming of microbial dysbiosis and macrophage polarization to attenuate liver fibrosis in offspring of obese mice. Hepatol Commun. 2018 Jan; 2(3):313–328. https://doi.org/10.1002/hep4.1139
- Fröhlich E, Wahl R. Microbiota and thyroid interaction in health and disease. Trends Endocrinol Metab. 2019 Aug;30(8):479–490. https://doi.org/10.1016/j.tem.2019.05.008
- Fuhri Snethlage CM, Nieuwdorp M, van Raalte DH, Rampanelli E, Verchere BC, Hanssen NMJ. Auto-immunity and the gut microbiome in type 1 diabetes: Lessons from rodent and human studies. Best Pract Res Clin Endocrinol Metab. 2021 May;35(3):101544. https://doi.org/10.1016/j.beem.2021.101544
- Geng Q, Gao H, Yang R, Guo K, Miao D. Pyrroloquinoline quinone prevents estrogen deficiency-induced osteoporosis by inhibiting oxidative stress and osteocyte senescence. Int J Biol Sci. 2019 Jan; 15(1):58–68. https://doi.org/10.7150/ijbs.25783
- Hauge JG. Glucose dehydrogenase of Bacterium anitratum: An enzyme with a novel prosthetic group. J Biol Chem. 1964 Nov;239:3630–3639.
- Hoang TD, Stocker DJ, Chou EL, Burch HB. 2022 Update on clinical management of Graves disease and thyroid eye disease. Endocrinol Metab Clin North Am. 2022 Jun;51(2):287–304. https://doi.org/10.1016/j.ecl.2021.12.004
- Huang C, Ming D, Wang W, Wang Z, Hu Y, Ma X, Wang F. Pyrro-loquinoline quinone alleviates jejunal mucosal barrier function damage and regulates colonic microbiota in piglets challenged with enterotoxigenic Escherichia coli. Front Microbiol. 2020 Jul;11:1754. https://doi.org/10.3389/fmicb.2020.01754
- Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota. World J Gastroenterol. 2015 Aug;21(29):8787–8803. https://doi.org/10.3748/wjg.v21.i29.8787
- Jiang W, Yu X, Kosik RO, Song Y, Qiao T, Tong J, Liu S, Fan S, Luo Q, Chai L, et al. Gut microbiota may play a significant role in the pathogenesis of Graves’ disease. Thyroid. 2021 May;31(5):810–820. https://doi.org/10.1089/thy.2020.0193
- Jonscher KR, Chowanadisai W, Rucker RB. Pyrroloquinoline-quinone is more than an antioxidant: A vitamin-like accessory factor important in health and disease prevention. Biomolecules. 2021 Sep;11(10):1441. https://doi.org/10.3390/biom11101441
- Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023 Jan;51(D1):D587–D592. https://doi.org/10.1093/nar/gkac963
- Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000 Jan;28(1):27–30. https://doi.org/10.1093/nar/28.1.27
- Knezevic J, Starchl C, Tmava Berisha A, Amrein K. Thyroid-gutaxis: How does the microbiota influence thyroid function? Nutrients. 2020 Jun;12(6):1769. https://doi.org/10.3390/nu12061769
- Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Jones SJ, Marra MA. Circos: An information aesthetic for comparative genomics. Genome Res. 2009 Sep;19(9):1639–1645. https://doi.org/10.1101/gr.092759.109
- Kumar N, Kar A, Panda S. Pyrroloquinoline quinone ameliorates L-thyroxine-induced hyperthyroidism and associated problems in rats. Cell Biochem Funct. 2014 Aug;32(6):538–546. https://doi.org/10.1002/cbf.3048
- Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013 Sep; 31(9):814–821. https://doi.org/10.1038/nbt.2676
- Lin L, Zhang J. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunol. 2017 Jan;18(1):2. https://doi.org/10.1186/s12865-016-0187-3
- Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P, Balamurugan R. The Firmicutes/Bacteroidetes ratio: A relevant marker of gut dysbiosis in obese patients? Nutrients. 2020 May; 12(5): 1474. https://doi.org/10.3390/nu12051474
- Magoč T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 2011 Nov; 27(21): 2957–2963. https://doi.org/10.1093/bioinformatics/btr507
- Miettinen M, Lehtonen A, Julkunen I, Matikainen S. Lactobacilli and Streptococci activate NF-kappa B and STAT signaling pathways in human macrophages. J Immunol. 2000 Apr;164(7):3733–3740. https://doi.org/10.4049/jimmunol.164.7.3733
- Mohamad Ishak NS, Ikemoto K. Pyrroloquinoline-quinone to reduce fat accumulation and ameliorate obesity progression. Front Mol Biosci. 2023 May;10:1200025. https://doi.org/10.3389/fmolb.2023.1200025
- Moshkelgosha S, Verhasselt HL, Masetti G, Covelli D, Biscarini F, Horstmann M, Daser A, Westendorf AM, Jesenek C, Philipp S, et al.; INDIGO consortium. Modulating gut microbiota in a mouse model of Graves’ orbitopathy and its impact on induced disease. Microbiome. 2021 Feb;9(1):45. https://doi.org/10.1186/s40168-020-00952-4
- Neag EJ, Smith TJ. 2021 update on thyroid-associated ophthalmopathy. J Endocrinol Invest. 2022 Feb;45(2):235–259. https://doi.org/10.1007/s40618-021-01663-9
- Nishino K, Nishida A, Inoue R, Kawada Y, Ohno M, Sakai S, Inatomi O, Bamba S, Sugimoto M, Kawahara M, et al. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease. J Gastroenterol. 2018 Jan;53(1):95–106. https://doi.org/10.1007/s00535-017-1384-4
- Ouchi A, Ikemoto K, Nakano M, Nagaoka S, Mukai K. Kinetic study of aroxyl radical scavenging and α-tocopheroxyl regeneration rates of pyrroloquinolinequinol (PQQH2, a reduced form of pyrroloquinolinequinone) in dimethyl sulfoxide solution: finding of synergistic effect on the reaction rate due to the coexistence of α-tocopherol and PQQH2. J Agric Food Chem. 2013 Nov; 61(46): 11048–11060. https://doi.org/10.1021/jf4040496
- Qu X, Zhai B, Liu Y, Chen Y, Xie Z, Wang Q, Wu Y, Liu Z, Chen J, Mei S, et al. Pyrroloquinoline quinone ameliorates renal fibrosis in diabetic nephropathy by inhibiting the pyroptosis pathway in C57BL/6 mice and human kidney 2 cells. Biomed Pharmacother. 2022 Jun;150:112998. https://doi.org/10.1016/j.biopha.2022.112998
- Sasakura H, Moribe H, Nakano M, Ikemoto K, Takeuchi K, Mori I. Lifespan extension by peroxidase and dual oxidase-mediated ROS signaling through pyrroloquinoline quinone in C.elegans. J Cell Sci. 2017 Aug;130(15):2631–2643. https://doi.org/10.1242/jcs.202119
- Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biol. 2011 Jun;12(6):R60. https://doi.org/10.1186/gb-2011-12-6-r60
- Sherid M, Samo S, Sulaiman S, Husein H, Sifuentes H, Sridhar S. Liver abscess and bacteremia caused by lactobacillus: role of probiotics? Case report and review of the literature. BMC Gastroenterol. 2016 Nov;16(1):138. https://doi.org/10.1186/s12876-016-0552-y
- Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013 Aug;341(6145):569–573. https://doi.org/10.1126/science.1241165
- Taylor PN, Zhang L, Lee RWJ, Muller I, Ezra DG, Dayan CM, Kahaly GJ, Ludgate M. New insights into the pathogenesis and non-surgical management of Graves orbitopathy. Nat Rev Endocrinol. 2020 Feb;16(2):104–116. https://doi.org/10.1038/s41574-019-0305-4
- Wang Q, Garrity GM, Tiedje JM, Cole JR. Naïve Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007 Aug;73(16):5261–5267. https://doi.org/10.1128/AEM.00062-07
- Wei Y, Li Y, Yan L, Sun C, Miao Q, Wang Q, Xiao X, Lian M, Li B, Chen Y, et al. Alterations of gut microbiome in autoimmune hepatitis. Gut. 2020 Mar;69(3):569–577. https://doi.org/10.1136/gutjnl-2018-317836
- Wémeau JL, Klein M, Sadoul JL, Briet C, Vélayoudom-Céphise FL. Graves’ disease: Introduction, epidemiology, endogenous and environmental pathogenic factors. Ann Endocrinol. 2018 Dec;79(6): 599–607. https://doi.org/10.1016/j.ando.2018.09.002
- Yin X, Ming D, Bai L, Wu F, Liu H, Chen Y, Sun L, Wan Y, Thacker PA, Wu G, et al. Effects of pyrroloquinoline quinone supplementation on growth performance and small intestine characteristics in weaned pigs. J Anim Sci. 2019 Jan;97(1):246–256. https://doi.org/10.1093/jas/sky387